24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

OBJECTIVE: The objective of this study was to evaluate the safety and intraocular pressure (IOP)-lowering effects over 24 months of biodegradable bimatoprost sustained-release implant (Bimatoprost SR) administration versus topical bimatoprost 0.03% in patients with open-angle glaucoma (OAG). METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs
Main Authors: Craven, E. Randy, Walters, Thomas, Christie, William C., Day, Douglas G., Lewis, Richard A., Goodkin, Margot L., Chen, Michelle, Wangsadipura, Veronica, Robinson, Michael R., Bejanian, Marina
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007425/
https://ncbi.nlm.nih.gov/pubmed/31884564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01248-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados